S 5510
Open Payments Expansion Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Open Payments Expansion Act, aims to increase transparency in the pharmaceutical and medical device industries by requiring manufacturers to publicly disclose payments they make to patient advocacy groups. Currently, these payments are not always reported, making it difficult to assess potential influence on patient advocacy efforts. The bill expands the existing Open Payments program to include these new disclosures, starting in 2026, and clarifies the definition of what constitutes a ‘covered payment’ and a ‘patient advocacy organization.’
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.